Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Anixa Biosciences Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 58 | 2 | 57 | +1 |
| Shares | 5.61M | 26.2K | 5.84M | +252.6K (+4.5%) |
| Value | $17.6M | $82.4K | $13.6M | −$3.92M (−22.4%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Anixa Biosciences Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 70,000 | $162.4K | 0.00% |
| Jane Street Group, LLC | 28,846 | $66.9K | 0.00% |
| Kestra Advisory Services, LLC | 28,000 | $65.0K | 0.00% |
| Prosperity Wealth Management, Inc. | 23,100 | $53.6K | 0.02% |
| Engineers Gate Manager LP | 17,994 | $41.7K | 0.00% |
| Millennium Management LLC | 11,028 | $25.6K | 0.00% |
| MAI Capital Management | 2,920 | $6.78K | 0.00% |
| Stephens Consulting, LLC | 1,000 | $2.32K | 0.00% |
| Crowley Wealth Management, Inc. | 1,000 | $2.32K | 0.00% |
| SBI Securities Co., Ltd. | 231 | $536 | 0.00% |
Sold out (9)
Institutions that held Anixa Biosciences Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Marshall Wace, LLP | 44,483 | $140.1K |
| Cambridge Investment Research Advisors, Inc. | 41,104 | $129.0K |
| Stratos Wealth Partners, LTD. | 15,000 | $47.3K |
| Virtu Financial LLC | 10,786 | $34.0K |
| Simplex Trading, LLC | 8,571 | $26.0K |
| Advisory Services Network, LLC | 11,174 | $24.7K |
| Steward Partners Investment Advisory, LLC | 3,144 | $9.90K |
| Livelsberger Financial Advisory | 1,634 | $5.15K |
| Avion Wealth | 200 | $0 |
Not filed for Q4 2024 yet (2)
Institutions that held Anixa Biosciences Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 15,752 | $49.6K |
| LifePro Asset Management | 10,410 | $32.8K |